BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

British Journal of Ophthalmology 2005;89:1356-1362; doi:10.1136/bjo.2004.064147
Copyright © 2005 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Read responses to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mehta, J S
Right arrow Articles by Allan, B D S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mehta, J S
Right arrow Articles by Allan, B D S

EXTENDED REPORT

Hydroxyapatite promotes superior keratocyte adhesion and proliferation in comparison with current keratoprosthesis skirt materials

J S Mehta1,2, C E Futter2, S R Sandeman3, R G A F Faragher3, K A Hing4, K E Tanner4, B D S Allan1,2

1 Cornea & External Disease Service, Moorfields Eye Hospital, London, UK
2 Division of Cell Biology, Institute of Ophthalmology, London, UK
3 University of Brighton, School of Pharmacy and Biomolecular Science, University of Brighton, Brighton, UK
4 IRC in Biomedical Materials, Queen Mary University of London, London, UK

Correspondence to:
Correspondence to:
MrJ S Mehta
Moorfields Eye Hospital, City Road, London EC1V 2PD, UK; jodmehta{at}gmail.com

Aim: Published clinical series suggest the osteoodontokeratoprosthesis (OOKP) may have a lower extrusion rate than current synthetic keratoprostheses. The OOKP is anchored in the eye wall by autologous tooth. The authors’ aim was to compare adhesion, proliferation, and morphology for telomerase transformed keratocytes seeded on calcium hydroxyapatite (the principal mineral constituent of tooth) and materials used in the anchoring elements of commercially available synthetic keratoprostheses.

Methods: Test materials were hydroxyapatite, polytetrafluoroethylene (PTFE), polyhydroxyethyl methacrylate (HEMA), and glass (control). Cell adhesion and viability were quantified at 4 hours, 24 hours, and 1 week using a calcein-AM/EthD-1 viability/cytotoxicity assay. Focal contact expression and cytoskeletal organisation were studied at 24 hours by confocal microscopy with immunoflourescent labelling. Further studies of cell morphology were performed using light and scanning electron microscopy.

Results: Live cell counts were significantly greater on hydroxyapatite surfaces at each time point (p<0.04). Dead cell counts were significantly higher for PTFE at 7 days (p<0.002). ß1 integrin expression was highest on hydroxyapatite. Adhesion structures were well expressed in flat, spread out keratocytes on both HA and glass. Keratocytes tended to be thinner and spindle shaped on PTFE. The relatively few keratocytes visible on HEMA test surfaces were rounded and poorly adherent.

Conclusions: Keratocyte adhesion, spreading, and viability on hydroxyapatite test surfaces is superior to that seen on PTFE and HEMA. Improving the initial cell adhesion environment in the skirt element of keratoprostheses may enhance tissue integration and reduce device failure rates.


Abbreviations: BSA, bovine serum albumin; Ethd-1, ethidium homodimer-1; HEMA, polyhydroxyethyl methacrylate; OOKP, osteoodontokeratoprosthesis; PBS, phosphate buffered saline; PTFE, polytetrafluoroethylene; PHEMA, poly(2-hydroxyethyl methacrylate)

Keywords: keratoprosthesis; osteoodontokeratoprosthesis; hydroxyapatite; polytetrafluoroethylene; PHEMA




This article has been cited by other articles:


Home page
Br. J. Ophthalmol.Home page
C Liu, S Okera, R Tandon, J Herold, C Hull, and S Thorp
Visual rehabilitation in end-stage inflammatory ocular surface disease with the osteo-odonto-keratoprosthesis: results from the UK
Br. J. Ophthalmol., September 1, 2008; 92(9): 1211 - 1217.
[Abstract] [Full Text] [PDF]


Home page
J Biomater ApplHome page
Y.-F. Zhang, X.-R. Cheng, Yun Chen, Bin Shi, X.-H. Chen, D.-X. Xu, and Jin Ke
Three-dimensional Nanohydroxyapatite/Chitosan Scaffolds as Potential Tissue Engineered Periodontal Tissue
J Biomater Appl, April 1, 2007; 21(4): 333 - 349.
[Abstract] [PDF]


Home page
Br. J. Ophthalmol.Home page
E J Hollick, S L Watson, J K G Dart, P J Luthert, and B D S Allan
Legeais BioKpro III keratoprosthesis implantation: long term results in seven patients.
Br. J. Ophthalmol., September 1, 2006; 90(9): 1146 - 1151.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
C R Hicks, T V Chirila, S Vijayasekaran, and G J Crawford
PHEMA as a keratoprosthesis material
Br. J. Ophthalmol., January 1, 2006; 90(1): 124 - 124.
[Full Text] [PDF]

eLetters:

Read all eLetters

PHEMA as a keratoprosthesis material
Celia R Hicks, et al.
BJO Online, 3 Oct 2005 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd.